Use of Anticoagulant, and Associated Factors of Anticoagulant Refusal Atrial Fibrillation Patients
Prevalence of Use of Anticoagulant, and Associated Factors of Anticoagulant Refusal in Non-valvular Atrial Fibrillation Patients---- A Study in Hong Kong General Out-patient Clinic
Atrial fibrillation is a clinically significant cardiac arrhythmia that increases the risk of stroke by 3 to 4 times. Oral anticoagulation has been shown to mitigate stroke risk by two-thirds among patients with AF and is widely recommended in optimizing AF management.Direct oral anticoagulants have also been demonstrated to be superior to warfarin with respect to the risk of fatal bleeding and stroke prevention.
However, the previous study finding highlighted a great gap between current guidelines and the clinical management of AF .Nonetheless, the decision for anticoagulant use is not straightforward.It is worth to investigate the updated prevalence of anticoagulant use, the reasons for not receiving anticoagulant, and the factors independently associated with anticoagulant refusal in patients with non-valvular atrial fibrillation.
研究概览
研究类型
注册 (预期的)
联系人和位置
学习地点
-
-
-
Hong Kong、香港
- LIAO, Jiawei
-
接触：
- LIAO Jiawei
- 电话号码：51718217
- 邮箱：mirachen2002@gmail.com
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- diagnosis as atrial fibrillation
- aged ≧18 years
- able to given consent
Exclusion Criteria:
- Unable/unwillingness to sign informed consent to study
- mechanical heart valve
- moderate-to-severe mitral stenosis
- Transient atrial fibrillation from reversible cause (e.g., during respiratory tract infection or bronchospasm)
- pregnancy
- hospitalization within 1 month prior to inclusion in the study.
学习计划
研究是如何设计的？
设计细节
- 观测模型：生态或社区
- 时间观点：横截面
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
The prevalence of anticoagulant use in non-valvular atrial fibrillation patients
大体时间：August 2019 to March 2020
|
calculate the prevalence of anticoagulant use in non-valvular atrial fibrillation patients
|
August 2019 to March 2020
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
the rate of the refusal of anticoagulant use
大体时间：August 2019 to March 2020
|
calculate the rate of refusal of anticoagulant use in the eligible non-valvular atrial fibrillation patients
|
August 2019 to March 2020
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (预期的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.
没有干预的临床试验
-
University of Illinois at ChicagoShirley Ryan AbilityLab; Oakland University; Access Living主动，不招人
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Northwestern University主动，不招人
-
Otsuka Pharmaceutical Factory, Inc.Celerion完全的